Professional Documents
Culture Documents
Prof.S.Shivakumar.MD.,
HOD & Professor ofMedicine
ofMedicine,,
Stanley medical college
Etiology
Infections
Bacterial
Viral
Protozoal
Malignancy
Leukemia, lymphoma
Infectious causes
Malaria
common cause
P.falciparum causes increased mortality/ morbidity.
leptospirosis
TB
Pulmonary
Extra pulmonarypulmonary- lymph node, meningeal, abdominal
etc.
CONTD
CONTD
Enteric fever
Viral fever
HIV
Resistance to drugs
Approach to fever
Fever
Duration of fever
Organ dysfunction
Cause of fever
Duration of fever
Viral fever
Organ dysfunction
Jaundice
Renal failure
Pneumonia/ ARDS
Meningitis/ encephalitis
Pulmonary
Bleeding diathesis
Dengue/ leptospirosis
Malaria
Clinical presentation
Uncomplicated
Complicated
Malaria - Uncomplicated
Clinical features
Hepatosplenomegaly
Wt. loss
Uncompli
Relapse 50%
Cerebral malaria
Shock
Severe anemia
Spontaneous bleeding
Renal failure
Hypoglycemia
ARDS
Acidemia
Repeated generalized
convulsions
Macroscopic
hemoglobinuria
Cerebral malaria
Renal failure
S.Creatinine > 3mg %
Urine output <400ml in 24 hrs in adults
< 12ml/kg in children
Spontaneous bleeding
Severe anemia
Normocytic anemia with Hct < 15% or Hb < 5g%
in presence of parasitemia > 10,000/mcl
Presentation
Shock
Pts with severe malaria develop sudden
hypotension Algid malaria
hypotension
Sepsis / dehydration
Acidemia
Hypoglycemia
Convulsions
Macroscopic hemoglobinuria
Jaundice
Clinical features
features Indian studies
Jaundice 60 %
ARF -- 6%
Anemia 26%
ARDS 5%
Hypoglycemia 1.5%
Shock-Shock
-- 10%
Jaundice- 28 cases
Mild (biliurbin 1.5
1.5--3)
3)-- 14
Severe (>3) -14
Treatment of uncomplicated
falciparum malaria
+ lumefantrine,
lumefantrine,
artesunate + amodiaquine,
amodiaquine,
artesunate + mefloquine,
mefloquine,
artesunate + sulfadoxine
sulfadoxine
pyrimethamine.
artemether + lumefantrine
1tab = 20mg A + 120mg L .
4 tab/dose at 0,8,24,36,48,60(hr) to be taken with food
artesunate + amodiaquine
amodiaquine
50 mg AS Tab + 153 mg AQ Tab
4 tab AS OD for 3 days + 4 tab AQ OD for 3 days
artesunate + mefloquine
mefloquine
50 mg AS Tab & 250 mg MQ.
4 tab AS OD for 3 days + no MQ on day 1 , 3 tab on day 2 , 2 tab on
day 3.
artesunate + sulfadoxine
sulfadoxinepyrimethamine
50 mg AS Tab + 500 mg sulpha + 25 mg pyri/tab
4 tab AS OD for 3 days + 3 tab SP once on day 1
1. Artesunate2.4
Artesunate2.4 mg/kg body weight (2vials) IV at 0 hr, 12 hrs and 24 hrs
and then daily till the patient can take orally. Then AS 2 mg/kg body
weight per day (100 mg/day) to complete 7 days course.
2. Artemether 3.2 mg/kg body weight (2 amp) IM on admission then 1.6
mg/kg body weight (lamp) IM daily till patient can take orally. Then (40
mg caps) 2 caps daily orally to complete 7 day course.
3. Quininine Loading dose of 20 mg salt/kg in 1 pint 5% Dextrose Saline
in 4 hrs time, then10 mg salt/kg body weight (maximum 600 mg) to be
repeated 8 hourly. When the patient will be able to take orally give
Quinine 10 mg/kg body weight (maximum 600 mg) 8 hourly orally to
complete 7 days course.
*Doxycycline 3.5 mg/kg/day/Tetracycline/Clindamycin (Children and
Pregnancy) should be added when patient takes orally for 7 days with either
of 3 drugs mentioned above.
Leptospirosis
Introduction
Most common,
common, underreported and underdiagnosed zoonosis
Epidemiological factors
Contaminated environment
Rainfall
Epidemiology
Rainfall
Contaminated environment
Epidemiology..
Risk groups
Farmers Rice, Sugarcane, Vegetables, Cattle,
Pigs
Sewerage workers
Abattoirs, Butchers
Vetenarians , Lab staff
Miners
Fishermen Inland
Soldiers
Transmission
Rodents (Urine)
Contaminated environment
Domestic animals
Humans
Clinical Features
Anicteric
Myocarditis
Aseptic Meningoencephalitis
Ocular Manifestations
Anicteric (>90%)
Leptospiremic Phase
Fever
Myalgia
Conj.suffusion
Headache
Epistaxis
Abdominal pain
Immune Phase
Fever
Meningitis
Uveitis
Icteric Leptospirosis
LIVER
Pre
Pre--renal azotemia
ATN/ AIN
Oliguric/ NonNon-oliguric
Vascular injury
Occurs form Respiratory, Alimentary, Renal &
Genital tracts .
Hemorrhagic Pneumonitis
Cardiac
Hemorrhagic Myocarditis
Hypotension / Death
Arrhythmias
Aseptic MeningoEncephalitis
Ocular
CULTURE : Positive
MAT :
Seroconversion / 4 fold rise in the titre
High titre.
Problems In Diagnosis
No Reliable test
PCR Valuable
Serologic tests
Serological Tests
MAT
Gold Standard
Complicated, DFM required
Interpretation of Tests
>1/80 or >1/400
Possibilities
Rising
Declining
To
Interpretation of Tests
ELISA/SAT
MAT
INTERPRETATION
+
+
NA
+
+
Rising titres
Current Infection
Current Infection
Past infection
Current Infection
0 1 week
ELISA/SAT
MAT
1 month
2 months 1 yr
5 yrs
Blood culture
PCR
ELISA / MSAT
Confirm
( if available )
Negative
Positive
MAT
Approach ..
MAT
Positive
High titre
Rising titre
Negative
Repeat
Seroconversion
Treatment
Mild Leptospirosis
Severe Leptospirosis
Ampicillin 1 gm IV qid
Supportive Treatment
IV
Fluids
Analgesics
Dialysis
Mortality
Renal
failure
Cardiovascular
Bleeding
complications
Dengue fever
Clinical manifestations
Dengue fever
Fever / Headache /
Myalgia
Dengue
Hemorrhagic
fever
Above +
Thrombocytopenia +
Spontaneous Bleeding +
Plasma leakage
Above + shock
Dengue Shock
syndrome
Grading of severity
Disease course
Febrile phase 22-7 days
Afebrile phase 22-3 days
(critical phase)
Convalescent phase
Pathogenesis of DHF
capillary leak
Thrombocytopenia
DIC
Investigations
Confirm diagnosis of DF
> 20
20%
% rise in Hct
> 20
20%
% drop in Hct following treatment
Signs of plasma leakage pleural effusion,
ascites, hypoproteinemia
Febrile phase
Bed rest
Paracetamol 4times/day
Avoid Aspirin & Brufen
Avoid antibiotics
Oral Rehydration therapy fluid loss due to
vomiting / high temp. (2.5(2.5-4 litres /day)
Afebrile phase
Initiate IV fluid therapy (6ml/kg/Hr)
Crystalloid solution (GNS/RL) 1 - 2 hrs
Improvement
Reduce fluid therapy (3ml/kg/Hr) 6 -12 hrs discontinue
after 24 Hrs
Contd..
No Improvement
Increase fluid therapy crystalloids (10ml/kg/Hr)
for 2 Hrs
Improvement
reduce fluids 10ml 6ml 3ml/kg/Hr
discontinue after 24 -48 hrs.
DHF
CRYSTALLOIDS
(RL/DNS)
6ml/kg/hr
Improvement
3ml/kg/hr
Discontinue after
6-12 hrs
CRYSTALLOIDS
discontinue
improvement
Crystalloids
10-6-3ml
Improvement
Reduce fluid 20
20--10
10ml/kg
ml/kg , 10
10--6ml/kg 6-3ml/kg
Discontinue 24
24--48 hrs later
Contd
No
Improvement
- crystalloid as above
DSS
CRYSTALLOIDS
(10-20 ml/kg/hr)
Improvement
CRYSTALLOIDS No Improvement
Reduce
10-6-3ml/kg/hr
Blood (Hct )
Plasma (Hct )
CRYSTALLOID
10-6-3ml
discontinue
Cont
Sepsis
Definitions
Defini
organ dysfunction
CVS
Renal
Jaundice
CNS
Hepatic
Altered sensorium
RS
ARDS
Defini..
Septic shock
Sepsis with hypotension (SBP <90 mmHg) for at least 1 hr
despite adequate fluid therapy OR
Need for vasopressors to maintain systolic BP >90mmHg
Pneumonia
UTI
Cellulitis
Predisposing factors
Diabetes
Cirrhosis liver
Burns
Indwelling catheter
Neutropenia
Cholecystitis
Meningitis
Abscess
Organ dysfunction
CVS
Renal
Jaundice
CNS
Hepatic
Altered sensorium
RS
ARDS
Lab findings
Leukocytosis or leucopenia
Thrombocytopenia
Hyperbilirubinemia
Proteinuria
Low fibrinogen
Metabolic acidosis
Fibrin degradation products
D- dimers
cultures
Management
Elimination of source
Broad spectrum antibiotics
Ceftriaxone or ticaricillinticaricillin-clavulanate +
gentamicin
Ciprofloxacin + clindamycin
Vancomycin added if MRSA infections
Fluid resuscitation
Steroids
Activated protein C
Ventilator and ICU care for MODS and shock
Investigations
Blood
Complete hemogramhemogram- Hb/TC/DC/ESR/ Platelet/
peripheral smear
Blood sugar
LFT
RFT
S.Creatinine
Bl.urea
Contd..
Chest XX-ray
Ultrasound-- abdomen
Ultrasound
ECG
ABG
Urine analysis
Blood
urine
Investigation-- specific
Investigation
TB
Algorithmic approach
Fever
Organ dysfunction
No Organ dysfunction
Jaundice
Renal failure
ARDS
Shock
DIC/
Low platelet
Conclusion